UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM  8-K

CURRENT REPORT

__________________________________________

Pursuant to Section 13 or 15 (d) of

The Securities Exchange Act of 1934

December 7, 2009

Date of report (date of earliest event reported)

    FOREST LABORATORIES, INC.    

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of incorporation or organization)	1-5438 (Commission File Number)	11-1798614 (I.R.S. Employer Identification Number)
909 Third Avenue New York, New York (Address of principal executive offices)		10022-4731 (Zip code)

(212) 421-7850

(Registrant's telephone number, including area code)

                                                None                                             

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

1

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On December 7, 2009, the Board of Directors of Forest Laboratories, Inc. increased the number of members constituting the Board from eight to nine and appointed Peter J. Zimetbaum, M.D. to serve as a Director.  Dr. Zimetbaum is currently Director of Clinical Cardiology at the Beth Israel Deaconess Medical Center in Boston and an Associate Professor of Medicine at the Harvard School of Medicine in Boston.

Item 9.01. Financial Statements and Exhibits

(c)  Exhibit 99 Press release of Forest Laboratories, Inc. dated December 9, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date:  December 9, 2009

Forest Laboratories, Inc.

(Registrant)

/s/ Francis I. Perier, Jr.              

Francis I. Perier, Jr.

Senior Vice President - Finance and

Chief Financial Officer

2